These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 11118074

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
    Boström AC, Hejdeman B, Matsuda R, Fredriksson M, Fredriksson EL, Bratt G, Sandström E, Wahren B.
    Vaccine; 2004 Apr 16; 22(13-14):1683-91. PubMed ID: 15068851
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection.
    Feeney ME, Draenert R, Roosevelt KA, Pelton SI, McIntosh K, Burchett SK, Mao C, Walker BD, Goulder PJ.
    J Immunol; 2003 Dec 15; 171(12):6968-75. PubMed ID: 14662905
    [Abstract] [Full Text] [Related]

  • 5. Characterization of HIV-specific proliferative T cell responses in HIV-infected persons.
    Zhang Y, Huber M, Weissbrich B, Voss G, Langmann P, Klinker H, Jassoy C.
    AIDS Res Hum Retroviruses; 2001 May 01; 17(7):623-9. PubMed ID: 11375058
    [Abstract] [Full Text] [Related]

  • 6. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V, Popova D, Kicheva M, Todorova Y, Markova R, Martinova F, Elenkov I, Yankova M.
    Int Immunopharmacol; 2009 Jul 01; 9(7-8):831-6. PubMed ID: 19303058
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1949-57. PubMed ID: 17199938
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.
    d'Ettorre G, Forcina G, Andreotti M, Sarmati L, Palmisano L, Andreoni M, Vella S, Mastroianni CM, Vullo V.
    Clin Exp Immunol; 2004 Feb 05; 135(2):280-5. PubMed ID: 14738457
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.
    Blankson JN, Gallant JE, Siliciano RF.
    J Infect Dis; 2001 Feb 15; 183(4):657-61. PubMed ID: 11170994
    [Abstract] [Full Text] [Related]

  • 11. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
    Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD.
    Science; 1997 Nov 21; 278(5342):1447-50. PubMed ID: 9367954
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of proliferative responses to HIV-1 antigen in chronically HIV-infected patients under antiretroviral therapy.
    Mohm JM, Rump JA, Schulte-Mönting J, Schneider J.
    J Clin Virol; 2004 Jul 21; 30(3):239-42. PubMed ID: 15135742
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.
    Calarota SA, Leandersson AC, Bratt G, Hinkula J, Klinman DM, Weinhold KJ, Sandström E, Wahren B.
    J Immunol; 1999 Aug 15; 163(4):2330-8. PubMed ID: 10438897
    [Abstract] [Full Text] [Related]

  • 16. Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.
    Ratto-Kim S, Garner RP, Kim JH, Jagodzinski LL, Michael NL, Paris R, Redfield RR, Birx DL.
    J Infect Dis; 2004 Jun 01; 189(11):1988-95. PubMed ID: 15143464
    [Abstract] [Full Text] [Related]

  • 17. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
    Yamamura Y, Rodriguez N, Schwartz A, Eylar E, Yano N.
    Cell Mol Biol (Noisy-le-grand); 1995 Jun 01; 41 Suppl 1():S133-44. PubMed ID: 8574141
    [Abstract] [Full Text] [Related]

  • 18. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection.
    Musey LK, Krieger JN, Hughes JP, Schacker TW, Corey L, McElrath MJ.
    J Infect Dis; 1999 Aug 01; 180(2):278-84. PubMed ID: 10395840
    [Abstract] [Full Text] [Related]

  • 19. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA.
    HIV Med; 2004 Nov 01; 5(6):407-14. PubMed ID: 15544692
    [Abstract] [Full Text] [Related]

  • 20. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN, Shang H, Jiang YJ, Liu J, Dai D, Diao YY, Geng WQ, Jin X, Wang YN.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1966-71. PubMed ID: 17199940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.